PlainRecalls

DiaSorin Molecular LLC

8 recalls on record · Latest: Jul 26, 2023

Subscribe to new DiaSorin Molecular LLC recalls (RSS)

Agency notice ledger

Federal filing book DiaSorin Molecular LLC LIGHT-BOOK · SINGLE-AGENCY

#1,732 of 14,151 · 8 notices · 0.008% archive

  • BOOK 8 notices
  • RANK #1,732 of 14,151
  • SHARE 0.008% archive
  • AGENCY FDA Devices (8)
  • CAT medical devices
  • CATS 1 category
  • LATEST Jul 26, 2023
  • PHOTO Ab Sciex

Nearest notice-volume peer: Ab Sciex (0 notice gap)

DiaSorin Molecular LLC accounts for about 0.008% of the 104,423-notice archive on 8 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How DiaSorin Molecular LLC compares to 14,151 recalling firms

DiaSorin Molecular LLC ranks 1,732nd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

DiaSorin Molecular LLC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

8 1732nd of 14151 higher than 12,296 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

DiaSorin Molecular LLC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows DiaSorin Molecular LLC holds about 0.008% of archive notices alongside 8 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Devices Moderate Jul 26, 2023

Simplexa Direct Amplification Disc Kit, Rx Only, IVD The Simplexa Direct Amplification Disc Kit, REF: MOL1455 is 1 box containing 3 Direct Amplification Discs (DADs). Each box contains discs individually pouch-sealed and labeled with REF: MOL1452

FDA Devices Moderate Mar 15, 2023

Simplexa COVID-19 Direct, REF: MOL4150; including Reaction Mix, REF: MOL4150; with previous assay definition v2

FDA Devices Moderate Mar 15, 2023

Simplexa Flu A/B & RSV Direct Gen II, REF: MOL2655; including Reaction Mix REF: MOL2656; with previous assay definition v5.

FDA Devices Moderate Jan 12, 2022

Simplexa Direct Amplification Disc Kit, Product Kit Code MOL1455

FDA Devices Moderate Oct 27, 2021

SIMPLEXA COVID-19 Positive Control Pack, REF MOL4160, IVD, Rx Only, UDI: (01) 20816101027051

FDA Devices Moderate Jul 22, 2020

MOL3655 Simplexa VZV Swab Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster virus (VZV) DNA present in cutaneous and mucocutaneous lesion swabs from patients with signs and symptoms of VZV infection.

FDA Devices Moderate Jul 22, 2020

MOL2150 Simplexa HSV 1&2 Direct -CSF -Genital Swab -Cutaneous / Mucocutaneous Swabs Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection and differentiation of HSV-1 and HSV-2 present in cerebrospinal fluid (CSF), or cutaneous and mucocutaneous lesion swabs from patients with signs and symptoms of HSV-1 or HSV-2 infection of the central nervous system (CNS) or cutaneous and mucocutaneous lesions.

FDA Devices Moderate Jul 22, 2020

MOL3650 Simplexa VZV Direct - Product Usage: is intended for use on the LIAISON MDX instrument for the qualitative detection of varicella-zoster virus (VZV) DNA in cerebrospinal fluid (CSF) from patients with signs and symptoms of VZV infections of the central nervous system (CNS).

DiaSorin Molecular LLC holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (8 here).

Similar medical devices volume

Nearest multi-notice firms in the same narrow category lane.

Frequently Asked Questions

How many federal recall notices name DiaSorin Molecular LLC?
PlainRecalls indexes 8 distinct federal recall events naming DiaSorin Molecular LLC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does DiaSorin Molecular LLC sit among other recalling firms?
DiaSorin Molecular LLC ranks #1,732 of 14,151 by distinct recall-event count among 14,151 firms in this archive (87th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of DiaSorin Molecular LLC's notices?
FDA Devices accounts for 8 of this firm's 8 indexed notices.
What product category dominates DiaSorin Molecular LLC's filing book?
Filings for DiaSorin Molecular LLC span 1 product category, led by medical devices. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous?
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
DiaSorin Molecular LLC: 8 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Devices). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming DiaSorin Molecular LLC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026